GlassScriptPhysician profile
Christopher Drew Alexander
NPI 1336506153
$381.11
in general payments reported to CMS, 2019-2025
13 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.04 · 2022: $36.74 · 2023: $15.34 · 2024: $19.73 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $333.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $121.25 | 2025 | Epclusa |
| Axsome Therapeutics, INC. | $38.87 | 2025 | Auvelity, Symbravo |
| Janssen Pharmaceuticals, INC | $36.74 | 2022 | |
| Corium, LLC | $23.59 | 2025 | Azstarys |
| Xeris Pharmaceuticals, INC. | $22.41 | 2025 | Gvoke Hypopen |
| Dexcom, INC. | $22.21 | 2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $21.78 | 2025 | Freestyle Libre 3 |
| Boston Scientific Corporation | $19.73 | 2024 | Spaceoar Vue System - 10ml |
| Astrazeneca Pharmaceuticals LP | $16.73 | 2025 | Airsupra |
| Pfizer INC. | $16.60 | 2025 | |
| Merck Sharp & Dohme LLC | $15.34 | 2023 | Keytruda |
| Kowa Pharmaceuticals America, INC. | $14.82 | 2025 | Zoryve |
| Glaxosmithkline, LLC. | $11.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.